Donate now
EN FR

Environment and Lifestyle Epidemiology

Publications

All recent publications: 2026-2022

 

  1. Espina C, Ritchie D, Feliu A, Canelo-Aybar C, D’Souza E, Mitrou PN, et al. (2026). Developing evidence-based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region-specific codes. Int J Cancer. 158(1): 9-18. https://doi.org/10.1002/ijc.70068 PMID: 40741905
  2. Thorat MA, Arbyn M, Baldwin D, Castells X, Hofvind S, Ivanus U, et al. (2026). European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer. Mol Oncol. 20(1): 117-133. https://doi.org/10.1002/1878-0261.70158 PMID: 41250966
  3. Ahmed F, Romero Saletti S, D’Souza E, Espina C, Ritchie D, Barcelo AM, et al. (2025). Assessing the User Experience of the EU Mobile App for Cancer Prevention: Mixed Methods Study. JMIR Form Res. 9: e73844. https://doi.org/10.2196/73844 PMID: 40971579
  4. Ahmed F, Romero Saletti SM, D’Souza E, Espina C, Ritchie D, Barcelo AM, et al. (2025). Piloting a cancer awareness app across six European countries: a pre-post study. Front Public Health. 13: 1648212. https://doi.org/10.3389/fpubh.2025.1648212 PMID: 41089856
  5. Alhattab RAN, McKinley JM, Hunter RF, Delargy CM, Wallace SM, Bennett D, et al. (2025). Lung cancer burden attributable to ambient particulate matter: a nationally representative population-based case-control study. Br J Cancer. 133(12): 1872-1879. https://doi.org/10.1038/s41416-025-03207-x PMID: 41053161
  6. Barrera B, Feliu A, Espina C, Brand T, Zeeb H, Ahmed F (2025). Leveraging AI to Enhance Qualitative Research: Experiences and Recommendations From Case Studies in Cancer Prevention Literacy Across the European Union. International Journal of Qualitative Methods. 24. https://doi.org/10.1177/16094069251365766
  7. Bauer M, Santos P, Wilfer A, van den Berg E, Zietsman A, Vetter M, et al. (2025). HIV status alters immune cell infiltration and activation profile in women with breast cancer. Nat Commun. 16(1): 4699. https://doi.org/10.1038/s41467-025-59408-8 PMID: 40393975
  8. Bosch de Basea M, Thierry-Chef I, Harbron R, Hauptmann M, Byrnes G, Bernier MO, et al. (2025). Author Correction: Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 31(7): 2452. https://doi.org/10.1038/s41591-025-03689-5 PMID: 40217080
  9. Boucheron P, Zietsman A, Anele A, Offiah AU, Galukande M, Parham G, et al. (2025). Measuring the WHO Global Breast Cancer Initiative Pillars’ key performance indicators in Sub-Saharan Africa: experience in the African Breast Cancer-Disparities in Outcomes hospital-based cohort study. EClinicalMedicine. 81: 103104. https://doi.org/10.1016/j.eclinm.2025.103104 PMID: 40034567
  10. Brochez L, Volkmer B, Hoorens I, Garbe C, Rocken M, Schuz J, et al. (2025). Skin cancer in Europe today and challenges for tomorrow. J Eur Acad Dermatol Venereol. 39(2): 272-277. https://doi.org/10.1111/jdv.20368 PMID: 39377431
  11. Capucetti A, Falivene J, Pizzichetti C, Latino I, Mazzucchelli L, Schacht V, et al. (2025). Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination. Proc Natl Acad Sci U S A. 122(48): e2510392122. https://doi.org/10.1073/pnas.2510392122 PMID: 41289395
  12. Drozdovitch V, Lipikhina A, Apsalikov K, Brait Y, Tokanov A, Yessilkanov G, et al. (2025). Assessment of radiation contamination of villages in northeastern Kazakhstan not covered by exposure rate measurements after atmospheric nuclear weapons tests conducted at the Semipalatinsk nuclear test site. J Environ Radioact. 288: 107731. https://doi.org/10.1016/j.jenvrad.2025.107731 PMID: 40499259
  13. Feng X, Alcala K, Guida F, Goldberg M, Zins M, Leleu O, et al. (2025). Eligibility criteria for lung cancer screening in France: a modelling study. Lancet Reg Health Eur. 51: 101221. https://doi.org/10.1016/j.lanepe.2025.101221 PMID: 39968190
  14. Gonzalez-Gil EM, Matta M, Morales Berstein F, Cairat M, Nicolas G, Blanco J, et al. (2025). Associations between degree of food processing and all-cause and cause-specific mortality: a multicentre prospective cohort analysis in 9 European countries. Lancet Reg Health Eur. 50: 101208. https://doi.org/10.1016/j.lanepe.2024.101208 PMID: 39867840
  15. Guth M, Lefevre M, Coste A, Praud D, Perol O, Pilorget C, et al. (2025). Lifetime occupational and para-occupational exposure to organic solvents and testicular germ cell tumor risk: a French case-control study-TESTIS. Int J Epidemiol. 54(6): dyaf175. https://doi.org/10.1093/ije/dyaf175 PMID: 41206641
  16. Hassanzadeh-Rangi N, Hosseini B, Akhtari Y, Khosravi Y (2025). Development of National profile for occupational safety and health services in Iran (IRANOSH): a mixed-method study focusing on input and process indicators. BMC Public Health. 25(1): 1393. https://doi.org/10.1186/s12889-025-22564-z PMID: 40229830
  17. Hosseini B, McCarty R, Zins M, Goldberg M, Ribet C, Schreiver I, et al. (2025). Cohort Profile: The Cancer Risk Attributable to the Body Art of Tattooing (CRABAT) study. Int J Epidemiol. 54(4). https://doi.org/10.1093/ije/dyaf132 PMID: 40759413
  18. Hovanec J, Kendzia B, Olsson A, Schuz J, Kromhout H, Vermeulen R, et al. (2025). Socioeconomic Status, Smoking, and Lung Cancer: Mediation and Bias Analysis in the SYNERGY Study. Epidemiology. 36(2): 245-252. https://doi.org/10.1097/EDE.0000000000001807 PMID: 39435907
  19. Joffe M, Chen WC, Craig A, O’Neil DS, Neugut AI, Jacobson JS, et al. (2025). Overall survival, poverty differentials, and mediating pathways among women with breast cancer: South African Breast Cancer and HIV Outcomes cohort. Oncologist. 31(1). https://doi.org/10.1093/oncolo/oyaf408 PMID: 41389285
  20. Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. (2025). Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 31(4): 1154-1162. https://doi.org/10.1038/s41591-025-03502-3 PMID: 39994475
  21. Kochs S, Schiewe S, Foerster M, Hillmann K, Blankenstein C, Meinke MC, et al. (2025). Tat_BioV: tattoo ink exposure and biokinetics of selected tracers in a short-term clinical study of 24 subjects. Arch Toxicol. 99(4): 1341-1354. https://doi.org/10.1007/s00204-025-03959-8 PMID: 39888425
  22. Koczkodaj P, Damianos M, Jagielska B, Weiderpass E, Schuz J (2025). In the framework of the EU Trio Presidency-supporting the European Code Against Cancer. Lancet Reg Health Eur. 57: 101451. https://doi.org/10.1016/j.lanepe.2025.101451 PMID: 40917995
  23. Laplanche A, Guida F, Moissonnier M, Launay L, Beranger R, Lagroye I, et al. (2025). Associations between individual and geospatial characteristics and power of 4G signals received by mobile phones. Environ Res. 286(Pt 3): 123030. https://doi.org/10.1016/j.envres.2025.123030 PMID: 41061881
  24. Lipikhina A, Harbron R, Apsalikov K, Brait Y, Yessilkanov G, Drozdovitch V, et al. (2025). Radioactive contamination of southeast Abai oblast, Kazakhstan, from the Chinese nuclear weapons testing program at Lop Nor: an analytical review. J Radiat Res. 66(1): 24-30. https://doi.org/10.1093/jrr/rrae101 PMID: 39812315
  25. McCarty RD, Trabert B, Collin LJ, Millar MM, Kriebel D, Grieshober L, et al. (2025). Tattooing and risk of melanoma: a population-based case-control study in Utah. J Natl Cancer Inst. 117(12): 2495-2504. https://doi.org/10.1093/jnci/djaf235 PMID: 40839395
  26. Minarik L, Khoueiry R, Leskur M, Cahais V, Herceg Z, Glavina Durdov M, et al. (2025). Epigenetic Regulation of NKT-Cell-Related Gene Signatures and Prognostic Implications in Oropharyngeal Squamous Cell Carcinoma. Cancers (Basel). 17(22). https://doi.org/10.3390/cancers17223666 PMID: 41301032
  27. Mo T, Joffe M, Cubasch H, Galukande M, Parham G, Pinder L, et al. (2025). Breast cancer overall survival, annual risks of death, and survival gap apportionment in sub-Saharan Africa (ABC-DO): 7-year follow-up of a prospective cohort study. Lancet Glob Health. 13(10): e1681-e1690. https://doi.org/10.1016/S2214-109X(25)00273-6 PMID: 40975077
  28. Mo T, Partridge A, Joffe M, Cubasch H, Galukande M, Parham G, et al. (2025). Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 117(11): 2298-2307. https://doi.org/10.1093/jnci/djaf213 PMID: 40795175
  29. Mo T, Partridge A, Joffe M, Cubasch H, Galukande M, Parham G, et al. (2025). Survival deficits in young women with breast cancer in sub-Saharan Africa: the African Breast Cancer-Disparities in Outcomes cohort. J Natl Cancer Inst. 117(11): 2298-2307. https://doi.org/10.1093/jnci/djaf213 PMID: 40795175
  30. Motlhale M, Sitas F, de Villiers CB, Simba H, Feliu A, Chen WC, et al. (2025). Smokeless tobacco (snuff) and site-specific cancer risks in adult Black South African women: Findings from the Johannesburg Cancer Study. Int J Cancer. 156(10): 1916-1925. https://doi.org/10.1002/ijc.35293 PMID: 39679969
  31. Mulisa G, Pero-Gascon R, McCormack V, Bisanz JE, Talukdar FR, Abebe T, et al. (2025). Multiple mycotoxin exposure assessment through human biomonitoring in an esophageal cancer case-control study in the Arsi-Bale districts of Oromia region of Ethiopia. Int J Hyg Environ Health. 263: 114466. https://doi.org/10.1016/j.ijheh.2024.114466 PMID: 39306897
  32. Narh CT, Afetor M, Baiden FE, Agbeko A, Commeh ME, Aziato L, et al. (2025). Barriers to Breast Cancer Care for Women Presenting at District and Regional-Level Hospitals in Ghana: Findings From the African Breast Cancer-Disparities in Outcomes Ghana Study. JCO Glob Oncol. 11: e2500275. https://doi.org/10.1200/GO-25-00275 PMID: 41160780
  33. Olsson A, Schuz J, Bukhtiyarov I, Moissonnier M, Ostroumova E, Ferro G, et al. (2025). Cause-specific mortality among workers in asbestos mining and enrichment factories (Asbest Chrysotile Cohort Study) compared with the general population of Sverdlovsk Oblast, Russian Federation. J Occup Med Toxicol. 20(1): 37. https://doi.org/10.1186/s12995-025-00484-3 PMID: 41199374
  34. Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Schuz J (2025). Risk factors of neuroblastoma: a systematic review and meta-analysis. Front Public Health. 13: 1576101. https://doi.org/10.3389/fpubh.2025.1576101 PMID: 40636854
  35. Paries M, Teiti I, Aubry M, Patin E, Madec Y, Chung K, et al. (2025). Prevalence and associated factors of obesity, hypertension, and diabetes in French Polynesia: results from a nationwide cross-sectional study. Lancet Reg Health West Pac. 64: 101746. https://doi.org/10.1016/j.lanwpc.2025.101746 PMID: 41332903
  36. Park SH, Sugier PE, Asgari Y, Karimi M, Kaaks R, Fortner RT, et al. (2025). Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study. Thyroid. 35(4): 433-443. https://doi.org/10.1089/thy.2024.0548 PMID: 40137860
  37. Piedvache A, Rashed WM, Petridou ET, Mueller BA, Bonaventure A, Clavel J, et al. (2025). Maternal prenatal infection and childhood leukaemia: a Childhood Cancer and Leukemia International Consortium (CLIC) meta-analysis. Int J Epidemiol. 54(5): dyaf167. https://doi.org/10.1093/ije/dyaf167
  38. Pizzato M, McCormack V, Dossus L, Al-Alem U, Delpierre C, Lamy S, et al. (2025). Education level and risk of breast cancer by tumor subtype in the EPIC cohort. Int J Cancer. 157(4): 672-686. https://doi.org/10.1002/ijc.35413 PMID: 40170258
  39. Rabe F, Getachew S, Stroetmann CY, Mezger NCS, Gebremariam TY, Berhane B, et al. (2025). Time to pathologic diagnosis of suspicious breast lesions: An institution-based study in five Ethiopian hospitals. Int J Cancer. 157(5): 876-889. https://doi.org/10.1002/ijc.35436 PMID: 40207740
  40. Richardson DB, Laurier D, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, et al. (2025). Worker studies and their interpretation. J Radiol Prot. 45(3). https://doi.org/10.1088/1361-6498/ade68e PMID: 40654101
  41. Richardson DB, Laurier D, Leuraud K, Gillies M, Haylock R, Kelly-Reif K, et al. (2025). Site-specific cancer mortality after low-level exposure to ionizing radiation: findings from an update of the International Nuclear Workers Study (INWORKS). Am J Epidemiol. 194(5): 1285-1294. https://doi.org/10.1093/aje/kwae256 PMID: 39108174
  42. Schuz J, Soerjomataram I, Foerster M, Langselius O, Rohrmann S, Vineis P, et al. (2025). Climate change mitigation and synergies with primary cancer prevention in Europe: time to implement opportunities. J Natl Cancer Inst. 117(12): 2432-2440. https://doi.org/10.1093/jnci/djaf182 PMID: 40668754
  43. Shezi B, Street R, Nkosi V, Winde F, Nuernberger H, Schuz J, et al. (2025). Uranium concentration in children’s hair samples and residential soil samples near mine tailings facilities, in Johannesburg, South Africa. Environ Geochem Health. 47(12): 562. https://doi.org/10.1007/s10653-025-02874-2 PMID: 41217549
  44. Shezi B, Street R, Nkosi V, Winde F, Nuernberger H, Schuz J, et al. (2025). Uranium concentration in children’s hair samples and residential soil samples near mine tailings facilities, in Johannesburg, South Africa. Environ Geochem Health. 47(12): 562. https://doi.org/10.1007/s10653-025-02874-2 PMID: 41217549
  45. Simba H, McCormack V, Bilaba J, Mmbaga BT, Kini L, Mshana JA, et al. (2025). Non-melanoma skin cancer and HPV in persons with albinism: a call for research investment. Br J Cancer. 133(5): 599-603. https://doi.org/10.1038/s41416-025-03107-0 PMID: 40615714
  46. Stepanenko V, Kaprin A, Ivanov S, Shegay P, Bogacheva V, Shinkarev S, et al. (2025). Features of internal absorbed dose microdistribution in biological tissue irradiated by 31SiO2 microparticles compared with dose microdistribution from exposure to 56MnO2 particles. J Radiat Res. 66(1): 16-23. https://doi.org/10.1093/jrr/rrae096 PMID: 39699238
  47. Stepanenko V, Shinkarev S, Lipikhina A, Apsalikov K, Kaprin A, Ivanov S, et al. (2025). External radiation dose reconstruction for settlements near the Semipalatinsk nuclear test site, Kazakhstan, in the international multicenter study: a detailed review and comparative analysis of the initial data. J Radiat Res. 66(5): 496-508. https://doi.org/10.1093/jrr/rraf049 PMID: 40884744
  48. Stepanenko VF, Hoshi M, Zhumadilov KS, Ostroumova EV, Shinkarev SM, Kushugulova AR, et al. (2025). 80 years after the bombing of Hiroshima and Nagasaki: atomic tragedy. A brief analytical review of available archival documents and current research in the field of retrospective dosimetry. “Radiation and Risk” Bulletin of the National Radiation and Epidemiological Registry. 34(3): 116-130. https://doi.org/10.21870/0131-3878-2025-34-3-116-130
  49. Teshima A, Martinez C, Filippidis FT, Laverty AA, Vardavas CI, Feliu A, et al. (2025). Mapping indicators of tobacco and related product use: Unveiling challenges and variations in the Eurobarometer surveys over three decades. Tob Induc Dis. 23. https://doi.org/10.18332/tid/202651 PMID: 40241742
  50. Turuban M, Kromhout H, Vila J, Vallbona-Vistos M, De Vocht F, Baldi I, et al. (2025). Occupational exposure to radiofrequency electromagnetic fields and brain tumor risk: Application of the INTEROCC job-exposure matrix. Int J Cancer. 156(3): 538-551. https://doi.org/10.1002/ijc.35182 PMID: 39301814
  51. Amrenova A, Baudin C, Ostroumova E, Stephens J, Anderson R, Laurier D (2024). Intergenerational effects of ionizing radiation: review of recent studies from human data (2018-2021). Int J Radiat Biol. 100(9): 1253-1263. https://doi.org/10.1080/09553002.2024.2309917 PMID: 38319708
  52. Berrington de Gonzalez A, Masten SA, Bhatti P, Fortner RT, Peters S, Santonen T, et al. (2024). Advisory Group recommendations on priorities for the IARC Monographs. Lancet Oncol. 25(5): 546-548. https://doi.org/10.1016/S1470-2045(24)00208-0 PMID: 38621402
  53. Beyen TK, Seife E, Gurara AM, McCormack V, Taye G, Addissie A (2024). Spatiotemporal Distribution, Time to Treatment Outcome Clustering and Determinants of Esophageal Cancer in Ethiopia, a Scoping Study. Cancer Control. 31: 10732748241251712. https://doi.org/10.1177/10732748241251712 PMID: 38716644
  54. Bouaoun L, Byrnes G, Lagorio S, Feychting M, Abou-Bakre A, Beranger R, et al. (2024). Effects of Recall and Selection Biases on Modeling Cancer Risk From Mobile Phone Use: Results From a Case-Control Simulation Study. Epidemiology. 35(4): 437-446. https://doi.org/10.1097/EDE.0000000000001749 PMID: 38771708
  55. Businge L, Hagenimana M, Motlhale M, Bardot A, Liu B, Anastos K, et al. (2024). Stage at diagnosis and survival by stage for the leading childhood cancers in Rwanda. Pediatr Blood Cancer. 71(7): e31020. https://doi.org/10.1002/pbc.31020 PMID: 38668553
  56. Collins LG, Lindsay D, Lal A, Doan T, Schuz J, Jongenelis M, et al. (2024). A systematic review of the modelling and economic evaluation studies assessing regulatory options for e-cigarette use. Int J Drug Policy. 129: 104476. https://doi.org/10.1016/j.drugpo.2024.104476 PMID: 38851141
  57. Daniels RD, Bertke SJ, Kelly-Reif K, Richardson DB, Haylock R, Laurier D, et al. (2024). Updated findings on temporal variation in radiation-effects on cancer mortality in an international cohort of nuclear workers (INWORKS). Eur J Epidemiol. 39(11): 1277-1286. https://doi.org/10.1007/s10654-024-01178-6 PMID: 39576361
  58. Deltour I, Guida F, Ribet C, Zins M, Goldberg M, Schuz J (2024). Use of Mobile Phones and Radiofrequency-Emitting Devices in the COSMOS-France Cohort. Int J Environ Res Public Health. 21(11): 1514. https://doi.org/10.3390/ijerph21111514 PMID: 39595781
  59. Dubner J, Neugut AI, Joffe M, O’Neil DS, Ayeni OA, Chen WC, et al. (2024). The association of HIV status with triple-negative breast cancer in patients with breast cancer in South Africa: a cross-sectional analysis of case-only data from a prospective cohort study. Lancet Glob Health. 12(12): e1993-e2002. https://doi.org/10.1016/S2214-109X(24)00376-0 PMID: 39577973
  60. Espina C, Feliu A, Gonzalez Vingut A, Liddle T, Jimenez-Garcia C, Olaya-Caro I, et al. (2024). Population-Based Cancer Prevention Education Intervention Through mHealth: A Randomized Controlled Trial. J Med Syst. 48(1): 9. https://doi.org/10.1007/s10916-023-02026-y PMID: 38194118
  61. Feliu A, Barrera B, Drury A, Hâncean MG, Geanta M, Koczkodaj P, et al. (2024). Perceptions Towards the Adoption of Multi-Risk Factors Cancer Prevention Educational Tool Among European Union Citizens: A Multi-Country Qualitative Study Protocol. International Journal of Qualitative Methods. 23: 8. https://doi.org/10.1177/16094069241256276 PMID: WOS:001274152000001
  62. Feychting M, Schuz J, Toledano MB, Vermeulen R, Auvinen A, Harbo Poulsen A, et al. (2024). Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study. Environ Int. 185: 108552. https://doi.org/10.1016/j.envint.2024.108552 PMID: 38458118
  63. Feychting M, Schuz J, Toledano MB, Vermeulen R, Auvinen A, Harbo Poulsen A, et al. (2024). Response to the letter to the editor regarding “Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study”. Environ Int. 189: 108808. https://doi.org/10.1016/j.envint.2024.108808 PMID: 38870580
  64. Feychting M, Schuz J, Toledano MB, Vermeulen R, Auvinen A, Poulsen AH, et al. (2024). Response to the Letter to the Editor regarding “Mobile phone use and brain tumour risk – COSMOS, a prospective cohort study”. Environ Int. 187: 108664. https://doi.org/10.1016/j.envint.2024.108664 PMID: 38663236
  65. Galicia Pacheco SI, Catena A, Sanchez MJ, Rueda MDM, Aljarilla Sanchez L, Costas L, et al. (2024). Socio-Economic Inequalities in Beliefs About Cancer and its Causes: Evidence From two Population Surveys. Psychooncology. 33(12): e70035. https://doi.org/10.1002/pon.70035 PMID: 39625346
  66. Giulbudagian M, Battisini B, Baumler W, Blass Rico AM, Bocca B, Brungs C, et al. (2024). Lessons learned in a decade: Medical-toxicological view of tattooing. J Eur Acad Dermatol Venereol. 38(10): 1926-1938. https://doi.org/10.1111/jdv.20072 PMID: 38709160
  67. Guth M, Pilorget C, Lefevre M, Coste A, Danjou A, Dananche B, et al. (2024). Occupational exposure to organic solvents and the risk of developing testicular germ cell tumors (TESTIS study): Effect of combined exposure assessment on risk estimation. Scand J Work Environ Health. 50(5): 359-371. https://doi.org/10.5271/sjweh.4161 PMID: 38597023
  68. Harbron R, Berrington de Gonzalez A, Griffin K, Al-Nabulsi I, Thierry-Chef I, Wilson L, et al. (2024). The international society for radiation epidemiology and dosimetry (ISoRED). J Radiol Prot. 44(3): 6. https://doi.org/10.1088/1361-6498/ad746e PMID: 39197466
  69. Harbron RW (2024). Estimates of cardiovascular disease risk from CT scans may be premature. J Radiol Prot. 44(2): 3. https://doi.org/10.1088/1361-6498/ad4b27 PMID: 38770744
  70. Harbron RW (2024). IAEA Human Health Series report 42: Establishing and Improving Interventional Radiology. J Radiol Prot. 44(1): 3. https://doi.org/10.1088/1361-6498/ad2469 PMID: WOS:001158799800001
  71. Kim J, Macharia PM, McCormack V, Foerster M, Galukande M, Joffe M, et al. (2024). Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study. Lancet Glob Health. 12(7): e1111-e1119. https://doi.org/10.1016/S2214-109X(24)00138-4 PMID: 38788756
  72. Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, et al. (2024). Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study. Lancet Haematol. 11(10): e761-e769. https://doi.org/10.1016/S2352-3026(24)00240-0 PMID: 39222647
  73. Lupo PJ, Chambers TM, Mueller BA, Clavel J, Dockerty JD, Doody DR, et al. (2024). Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood Cancer and Leukemia International Consortium. Int J Cancer. 154(3): 434-447. https://doi.org/10.1002/ijc.34720 PMID: 37694915
  74. Menya D, Bouaoun L, Chepkomoi T, Simba H, Anabwani AA, Anabwani E, et al. (2024). Hot beverage consumption in the African Esophageal Cancer Corridor: A community-based thermal exposure measurement study across the lifespan. Cancer Epidemiol. 92: 102614. https://doi.org/10.1016/j.canep.2024.102614 PMID: 38986356
  75. Moirangthem R, Hosseini B, Patil A, George GS, Manjrekar A, Doibale P, et al. (2024). Occupations and the risk of buccal mucosa cancer in Indian men: A multi-centre case-control study. Cancer Epidemiol. 92: 102644. https://doi.org/10.1016/j.canep.2024.102644 PMID: 39153274
  76. Oana I, Hancean MG, Perc M, Lerner J, Mihaila BE, Geanta M, et al. (2024). Online Media Use and COVID-19 Vaccination in Real-World Personal Networks: Quantitative Study. J Med Internet Res. 26: e58257. https://doi.org/10.2196/58257 PMID: 39454189
  77. O’Driscoll J, Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, et al. (2024). Reproductive factors and mammographic density within the International Consortium of Mammographic Density: A cross-sectional study. Breast Cancer Res. 26(1): 139. https://doi.org/10.1186/s13058-024-01890-x PMID: 39350230
  78. Ohlander J, Kromhout H, Vermeulen R, Portengen L, Kendzia B, Savary B, et al. (2024). Respirable crystalline silica and lung cancer in community-based studies: impact of job-exposure matrix specifications on exposure-response relationships. Scand J Work Environ Health. 50(3): 178-186. https://doi.org/10.5271/sjweh.4140 PMID: 38264956
  79. Olsson A, Bouaoun L, Schuz J, Vermeulen R, Behrens T, Ge C, et al. (2024). Lung Cancer Risks Associated with Occupational Exposure to Pairs of Five Lung Carcinogens: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). Environ Health Perspect. 132(1): 17005. https://doi.org/10.1289/EHP13380 PMID: 38236172
  80. Ong SK, Abe SK, Gek Phua GL, Jayasekara H, Togawa K, Gatellier L, et al. (2024). Mapping recommendations towards an Asian Code Against Cancer (ACAC) as part of the World Code Against Cancer Framework: an Asian National Cancer Centers Alliance (ANCCA) initiative. Lancet Reg Health Southeast Asia. 24: 100316. https://doi.org/10.1016/j.lansea.2023.100316 PMID: 38756166
  81. Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Deltour I, Erdmann F, et al. (2024). Risk factors for childhood brain tumours: A systematic review and meta-analysis of observational studies from 1976 to 2022. Cancer Epidemiol. 88: 102510. https://doi.org/10.1016/j.canep.2023.102510 PMID: 38056243
  82. Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Deltour I, Erdmann F, et al. (2024). Response to comments on: “Maternal smoking and the risk of childhood brain tumors”. Cancer Epidemiol. 90: 102546. https://doi.org/10.1016/j.canep.2024.102546 PMID: 38383210
  83. Onyije FM, Dolatkhah R, Olsson A, Bouaoun L, Schuz J (2024). Environmental risk factors of Wilms tumour: A systematic review and meta-analysis. EJC Paediatr Oncol. 4: None. https://doi.org/10.1016/j.ejcped.2024.100178 PMID: 39678930
  84. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3): 100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID: 38325367
  85. Reedijk M, Portengen L, Auvinen A, Kojo K, Heinavaara S, Feychting M, et al. (2024). Regression calibration of self-reported mobile phone use to optimize quantitative risk estimation in the COSMOS study. Am J Epidemiol. 193(10): 1482-1493. https://doi.org/10.1093/aje/kwae039 PMID: 38751312
  86. Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, et al. (2024). Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023. Mol Oncol. 18(2): 245-279. https://doi.org/10.1002/1878-0261.13575 PMID: 38135904
  87. Sandoval-Diez N, Belackova L, Fernandes Veludo A, Jalilian H, Guida F, Deltour I, et al. (2024). Determining the relationship between mobile phone network signal strength and radiofrequency electromagnetic field exposure: protocol and pilot study to derive conversion functions. Open Res Eur. 4: 206. https://doi.org/10.12688/openreseurope.18285.2 PMID: 40291791
  88. Schuz J, Kovalevskiy E, Olsson A, Moissonnier M, Ostroumova E, Ferro G, et al. (2024). Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study). J Natl Cancer Inst. 116(6): 866-875. https://doi.org/10.1093/jnci/djad262 PMID: 38247448
  89. Simba H, Kapambwe S, Bates MJ, Anorlu R, Mutebi M, Guida F, et al. (2024). Impact of Cancer Across the Intergenerational Family: A Multidimensional Perspective From African Countries. JCO Glob Oncol. 10: e2400116. https://doi.org/10.1200/GO.24.00116 PMID: 39361909
  90. Simba H, Mutebi M, Galukande M, Mahamat-Saleh Y, Aglago E, Addissie A, et al. (2024). Cancer Care Terminology in African Languages. JAMA Netw Open. 7(8): e2431128. https://doi.org/10.1001/jamanetworkopen.2024.31128 PMID: 39212985
  91. Stepanenko V, Sato H, Kaprin A, Fujimoto N, Kushugulova A, Ivanov S, et al. (2024). Internal radiation dose estimates in organs of Wistar rats exposed to sprayed neutron-activated 31SiO2 microparticles: first results of international multicenter study. J Radiat Res. 65(6): 744-751. https://doi.org/10.1093/jrr/rrae063 PMID: 39388726
  92. Stepanenko V, Shinkarev S, Kaprin A, Apsalikov K, Ivanov S, Shegay P, et al. (2024). Comparison of external dose estimates using different retrospective dosimetry methods in the settlements located near Semipalatinsk Nuclear Test Site, Republic of Kazakhstan. J Radiat Res. 65(1): 36-46. https://doi.org/10.1093/jrr/rrad082 PMID: 37981331
  93. Steponaviciene R, Maceika E, Kesminiene A, Smailyte G (2024). Recent insights into trends of thyroid cancer incidence in Lithuanian population exposed to Chernobyl fallout early in life. Ecotoxicol Environ Saf. 283: 116789. https://doi.org/10.1016/j.ecoenv.2024.116789 PMID: 39067071
  94. Traini E, Smith RB, Vermeulen R, Kromhout H, Schuz J, Feychting M, et al. (2024). Headache in the international cohort study of mobile phone use and health (COSMOS) in the Netherlands and the United Kingdom. Environ Res. 248: 118290. https://doi.org/10.1016/j.envres.2024.118290 PMID: 38280529
  95. Wan W, Peters S, Portengen L, Olsson A, Schuz J, Ahrens W, et al. (2024). Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies. Am J Respir Crit Care Med. 209(2): 185-196. https://doi.org/10.1164/rccm.202306-0942OC PMID: 37812782
  96. Xu M, Ho V, Lavoue J, Olsson A, Schuz J, Richardson L, et al. (2024). Prevalent occupational exposures and risk of lung cancer among women: Results from the application of the Canadian Job-Exposure Matrix (CANJEM) to a combined set of ten case-control studies. Am J Ind Med. 67(3): 200-213. https://doi.org/10.1002/ajim.23562 PMID: 38192156
  97. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2024). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tob Control. 33(3): 295-301. https://doi.org/10.1136/tc-2022-057262 PMID: 36100264
  98. Aburto TC, Romieu I, Stern MC, Barquera S, Corvalán C, Hallal PC, et al. (2023). Latin American and the Caribbean Code Against Cancer 1st edition: Weight, physical activity, diet, breastfeeding, and cancer. Cancer Epidemiol. 86 Suppl 1: 102436. https://doi.org/10.1016/j.canep.2023.102436 PMID: 37852731
  99. Ayeni OA, Jofe M, Mapanga W, Chen WC, O’Neil DS, Phakathi B, et al. (2023). Correction: Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Res. 25(1): 14. https://doi.org/10.1186/s13058-023-01611-w PMID: 36721167
  100. Ayeni OA, Joffe M, Mapanga W, Chen WC, O’Neil DS, Phakathi B, et al. (2023). Multimorbidity and overall survival among women with breast cancer: results from the South African Breast Cancer and HIV Outcomes Study. Breast Cancer Res. 25(1): 7. https://doi.org/10.1186/s13058-023-01603-w PMID: 36691057
  101. Baena A, Paolino M, Villarreal-Garza C, Torres G, Delgado L, Ruiz R, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: Medical interventions including hormone replacement therapy and cancer screening. Cancer Epidemiol. 86 Suppl 1: 102446. https://doi.org/10.1016/j.canep.2023.102446 PMID: 37852728
  102. Bauer M, Vetter M, Stuckrath K, Yohannes M, Desalegn Z, Yalew T, et al. (2023). Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa. Cancer Immunol Res. 11(6): 720-731. https://doi.org/10.1158/2326-6066.CIR-22-0795 PMID: 37058582
  103. Baumann M, Celis J, Ringborg U, Heitor M, Berns A, Albreht T, et al. (2023). Engaging European society at the forefront of cancer research and care: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto: How discussions at the 5(th) Gago Conference on European Science policy led to the Heidelberg Manifesto. Mol Oncol. 17(6): 925-945. https://doi.org/10.1002/1878-0261.13423 PMID: 36938773
  104. Behrens T, Ge C, Vermeulen R, Kendzia B, Olsson A, Schuz J, et al. (2023). Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY). Int J Cancer. 152(4): 645-660. https://doi.org/10.1002/ijc.34272 PMID: 36054442
  105. Blanco E, Algranti E, Cifuentes LA, Lopez-Carrillo L, Mora AM, Rodriguez-Guzman J, et al. (2023). Latin America and the Caribbean Code Against cancer 1st edition: Environment, occupation, and cancer. Cancer Epidemiol. 86 Suppl 1: 102381. https://doi.org/10.1016/j.canep.2023.102381 PMID: 37852723
  106. Bosch de Basea Gomez M, Thierry-Chef I, Harbron R, Hauptmann M, Byrnes G, Bernier MO, et al. (2023). Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med. 29(12): 3111-3119. https://doi.org/10.1038/s41591-023-02620-0 PMID: 37946058
  107. Boucheron P, Anele A, Offiah AU, Zietsman A, Galukande M, Parham G, et al. (2023). Reproductive history and breast cancer survival: Findings from the African breast cancer-Disparities in outcomes cohort and implications of Africa’s fertility transition on breast cancer prognosis. Int J Cancer. 152(9): 1804-1816. https://doi.org/10.1002/ijc.34411 PMID: 36545890
  108. Boucheron P, Zietsman A, Pontac J, Hansen R, Anderson BO, Togawa K, et al. (2023). Analysis of the Breast Cancer Journey in Namibia. JAMA Network Open. 6(11): e2341402. https://doi.org/10.1001/jamanetworkopen.2023.41402 PMID: 37921764
  109. Camargo MC, Feliu A, Stern MC, Villarreal-Garza C, Ferreccio C, Espina C (2023). The Latin America and the Caribbean Code Against Cancer: an opportunity for empowerment and progress. Lancet Reg Health Am. 28: 100644. https://doi.org/10.1016/j.lana.2023.100644 PMID: 38076409
  110. Chasimpha S, Dos Santos Silva I, Martei YM, Grover S, Cubasch H, McCormack V (2023). Survival Disparities Between Patients with Breast Cancer With and Without HIV: A Research Framework. JCO Glob Oncol. 9: e2200330. https://doi.org/10.1200/GO.22.00330 PMID: 37075268
  111. Chung FF, Maldonado SG, Nemc A, Bouaoun L, Cahais V, Cuenin C, et al. (2023). Buffy coat signatures of breast cancer risk in a prospective cohort study. Clin Epigenetics. 15(1): 102. https://doi.org/10.1186/s13148-023-01509-6 PMID: 37309009
  112. Espina C, Feliu A, Maza M, Almonte M, Ferreccio C, Finck C, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: 17 cancer prevention recommendations to the public and to policy-makers (World Code Against Cancer Framework). Cancer Epidemiol. 86 Suppl 1: 102402. https://doi.org/10.1016/j.canep.2023.102402 PMID: 37852725
  113. Feng X, Muller DC, Zahed H, Alcala K, Guida F, Smith-Byrne K, et al. (2023). Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. EBioMedicine. 92: 104623. https://doi.org/10.1016/j.ebiom.2023.104623 PMID: 37236058
  114. Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, et al. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 115(9): 1050-1059. https://doi.org/10.1093/jnci/djad071 PMID: 37260165
  115. Foerster M, Dufour L, Baumler W, Schreiver I, Goldberg M, Zins M, et al. (2023). Development and Validation of the Epidemiological Tattoo Assessment Tool to Assess Ink Exposure and Related Factors in Tattooed Populations for Medical Research: Cross-sectional Validation Study. JMIR Form Res. 7: e42158. https://doi.org/10.2196/42158 PMID: 36630184
  116. Guth M, Coste A, Lefevre M, Deygas F, Danjou A, Ahmadi S, et al. (2023). Testicular germ cell tumour risk by occupation and industry: a French case-control study – TESTIS. Occup Environ Med. 80(7): 407-417. https://doi.org/10.1136/oemed-2022-108601 PMID: 37230752
  117. Guth M, Lefevre M, Pilorget C, Coste A, Ahmadi S, Danjou A, et al. (2023). Parental occupational exposure to solvents and risk of developing testicular germ cell tumors among sons: a French nationwide case-control study (TESTIS study). Scandinavian Journal of Work Environment & Health. 49(6): 405-418. https://doi.org/10.5271/sjweh.4102 PMID: 37649372
  118. Hauptmann M, Byrnes G, Cardis E, Bernier MO, Blettner M, Dabin J, et al. (2023). Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study. Lancet Oncol. 24(1): 45-53. https://doi.org/10.1016/S1470-2045(22)00655-6 PMID: 36493793
  119. Hosseini B, Zendehdel K, Bouaoun L, Hall AL, Rashidian H, Hadji M, et al. (2023). Bladder cancer risk in relation to occupations held in a nationwide case-control study in Iran. Int J Cancer. 153(4): 765-774. https://doi.org/10.1002/ijc.34560 PMID: 37158123
  120. Kim J, Leon ME, Schinasi LH, Baldi I, Lebailly P, Freeman LEB, et al. (2023). Exposure to pesticides and risk of Hodgkin lymphoma in an international consortium of agricultural cohorts (AGRICOH). Cancer Causes Control. 34(11): 995-1003. https://doi.org/10.1007/s10552-023-01748-1 PMID: 37418114
  121. Lemos M, Restrepo J, Espina C, Feliu A, Ferreccio C, Garces-Palacio IC, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st edition: Formative research on the comprehension and persuasiveness of the recommendations by the general population. Cancer Epidemiol. 86 Suppl 1: 102456. https://doi.org/10.1016/j.canep.2023.102456 PMID: 37852727
  122. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID: 36241389
  123. Lucotte EA, Asgari Y, Sugier PE, Karimi M, Domenighetti C, Lesueur F, et al. (2023). Investigation of common genetic risk factors between thyroid traits and breast cancer. Hum Mol Genet. 33(1): 38-47. https://doi.org/10.1093/hmg/ddad159 PMID: 37740403
  124. Lung Cancer Cohort C (2023). The blood proteome of imminent lung cancer diagnosis. Nat Commun. 14(1): 3042. https://doi.org/10.1038/s41467-023-37979-8 PMID: 37264016
  125. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4): 373-389. https://doi.org/10.1007/s10654-023-00969-7 PMID: 36773182
  126. Mapanga W, Norris SA, Craig A, Ayeni OA, Chen WC, Jacobson JS, et al. (2023). Drivers of disparities in stage at diagnosis among women with breast cancer: South African breast cancers and HIV outcomes cohort. PLoS One. 18(2): e0281916. https://doi.org/10.1371/journal.pone.0281916 PMID: 36795733
  127. McDermott KT, Noake C, Wolff R, Bauld L, Espina C, Foucaud J, et al. (2023). Digital interventions to moderate physical inactivity and/or nutrition in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 5: 1185586. https://doi.org/10.3389/fdgth.2023.1185586 PMID: 37534029
  128. McDermott KT, Noake C, Wolff R, Espina C, Foucaud J, Steindorf K, et al. (2023). Digital interventions to moderate alcohol consumption in young people: a Cancer Prevention Europe overview of systematic reviews. Front Digit Health. 5: 1178407. https://doi.org/10.3389/fdgth.2023.1178407 PMID: 37288171
  129. Onyije FM, Olsson A, Bouaoun L, Schuz J (2023). Synthesized evidence for childhood acute lymphoblastic leukemia. Front Pediatr. 11: 1209330. https://doi.org/10.3389/fped.2023.1209330 PMID: 37565248
  130. Paul A, Danjou AMN, Deygas F, Guth M, Coste A, Lefevre M, et al. (2023). Parental occupations at birth and risk of adult testicular germ cell tumors in offspring: a French nationwide case-control study. Front Public Health. 11: 1303998. https://doi.org/10.3389/fpubh.2023.1303998 PMID: 38292387
  131. Pega F, Momen NC, Streicher KN, Leon-Roux M, Neupane S, Schubauer-Berigan MK, et al. (2023). Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000–2019: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 181: 108226. https://doi.org/10.1016/j.envint.2023.108226 PMID: 37945424
  132. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2): 203-213. https://doi.org/10.1002/ijc.34244 PMID: 36043555
  133. Reynales-Shigematsu LM, Barnoya J, Cavalcante T, Aburto TC, Romieu I, Stern MC, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st edition: Tobacco and nicotine-related products, secondhand smoke, and alcohol and cancer. Cancer Epidemiol. 86 Suppl 1: 102413. https://doi.org/10.1016/j.canep.2023.102413 PMID: 37852726
  134. Richardson DB, Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, et al. (2023). Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382: e074520. https://doi.org/10.1136/bmj-2022-074520 PMID: 37586731
  135. Robbins HA, Alcala K, Moez EK, Guida F, Thomas S, Zahed H, et al. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Ann Epidemiol. 77: 1-12. https://doi.org/10.1016/j.annepidem.2022.10.014 PMID: 36404465
  136. Schmutz A, Matta M, Cairat M, Espina C, Schuz J, Kampman E, et al. (2023). Mapping the European cancer prevention research landscape: A case for more prevention research funding. Eur J Cancer. 195: 113378. https://doi.org/10.1016/j.ejca.2023.113378 PMID: 37924646
  137. Schraw JM, Petridou ET, Bonaventure A, Dockerty JD, Karalexi M, Ntzani E, et al. (2023). Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium. Cancer Causes Control. 34(11): 1005-1015. https://doi.org/10.1007/s10552-023-01746-3 PMID: 37421504
  138. Schuz J, Espina C, Carvalho A, Maza M, Luciani S, Cazap E, et al. (2023). Latin America and the Caribbean Code Against Cancer 1st Edition: A landmark for cancer prevention in the region. Cancer Epidemiol. 86 Suppl 1: 102453. https://doi.org/10.1016/j.canep.2023.102453 PMID: 37852730
  139. Schuz J, Ostroumova E, Kesminiene A, Davies L, Ahn HS, Togawa K, et al. (2023). Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1]. Environ Health. 22(1): 13. https://doi.org/10.1186/s12940-022-00952-x PMID: 36703177
  140. Simba H, Kuivaniemi H, Abnet CC, Tromp G, Sewram V (2023). Environmental and life-style risk factors for esophageal squamous cell carcinoma in Africa: a systematic review and meta-analysis. BMC Public Health. 23(1): 21. https://doi.org/10.1186/s12889-023-16629-0 PMID: 37710248
  141. Simba H, Menya D, Mmbaga BT, Dzamalala C, Finch P, Mlombe Y, et al. (2023). The contribution of smoking and smokeless tobacco to oesophageal squamous cell carcinoma risk in the African oesophageal cancer corridor: Results from the ESCCAPE multicentre case-control studies. Int J Cancer. 152(11): 2269-2282. https://doi.org/10.1002/ijc.34458 PMID: 36733225
  142. Simba H, Mmbaga BT, Serventi F, Mremi A, Motlhale M, Espina C, et al. (2023). Why Am I Ill? Beliefs in Supernatural and Natural Causes of Ill Health at the Time of Diagnostic Workup of Patients With Esophageal Cancer in Tanzania. JCO Glob Oncol. 9: e2300100. https://doi.org/10.1200/GO.23.00100 PMID: 37883724
  143. Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, et al. (2023). Investigation of Shared Genetic Risk Factors Between Parkinson’s Disease and Cancers. Mov Disord. 38(4): 604-615. https://doi.org/10.1002/mds.29337 PMID: 36788297
  144. Zablotska LB, Zupunski L, Leuraud K, Lopes J, Hinkle J, Pugeda T, et al. (2023). Radiation and CNS effects: summary of evidence from a recent symposium of the Radiation Research Society. Int J Radiat Biol. 99(9): 1332-1342. https://doi.org/10.1080/09553002.2023.2142984 PMID: 36318723
  145. Zupunski L, Street R, Ostroumova E, Winde F, Sachs S, Geipel G, et al. (2023). Environmental exposure to uranium in a population living in close proximity to gold mine tailings in South Africa. J Trace Elem Med Biol. 77: 127141. https://doi.org/10.1016/j.jtemb.2023.127141 PMID: 36857995
  146. African Esophageal Cancer C (2022). Expanding oesophageal cancer research and care in eastern Africa. Nat Rev Cancer. 22(5): 253-254. https://doi.org/10.1038/s41568-022-00458-1 PMID: 35246668
  147. Ahmadi S, Guth M, Coste A, Bouaoun L, Danjou A, Lefevre M, et al. (2022). Paternal Occupational Exposure to Heavy Metals and Welding Fumes and Testicular Germ Cell Tumours in Sons in France. Cancers (Basel). 14(19). https://doi.org/10.3390/cancers14194962 PMID: 36230885
  148. Auvinen A, Cardis E, Blettner M, Moissonnier M, Sadetzki S, Giles G, et al. (2022). Diagnostic radiological examinations and risk of intracranial tumours in adults-findings from the Interphone Study. Int J Epidemiol. 51(2): 537-546. https://doi.org/10.1093/ije/dyab140 PMID: 34648614
  149. Ayeni OA, O’Neil DS, Pumpalova YS, Chen WC, Nietz S, Phakathi B, et al. (2022). Impact of HIV infection on survival among women with stage I-III breast cancer: Results from the South African breast cancer and HIV outcomes study. Int J Cancer. 151(2): 209-221. https://doi.org/10.1002/ijc.33981 PMID: 35218568
  150. Borkhardt A, Schuz J, Trubenbach C, Wellbrock M, Spix C, Erdmann F (2022). Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic. Leukemia. 36(12): 2908-2911. https://doi.org/10.1038/s41375-022-01730-x PMID: 36289349
  151. Chasimpha S, McCormack V, Cubasch H, Joffe M, Zietsman A, Galukande M, et al. (2022). Disparities in breast cancer survival between women with and without HIV across sub-Saharan Africa (ABC-DO): a prospective, cohort study. Lancet Hiv. 9(3): E160-E171. https://doi.org/10.1016/S2352-3018(21)00326-X PMID: 35245508
  152. Corbin S, Togawa K, Schuz J, Le Cornet C, Fervers B, Feychting M, et al. (2022). Parental occupational exposures in wood-related jobs and risk of testicular germ cell tumours in offspring in NORD-TEST a registry-based case-control study in Finland, Norway, and Sweden. Int Arch Occup Environ Health. 95(6): 1243-1253. https://doi.org/10.1007/s00420-021-01818-4 PMID: 34853884
  153. Deltour I, Poulsen AH, Johansen C, Feychting M, Johannesen TB, Auvinen A, et al. (2022). Time trends in mobile phone use and glioma incidence among males in the Nordic Countries, 1979-2016. Environ Int. 168: 107487. https://doi.org/10.1016/j.envint.2022.107487 PMID: 36041243
  154. Erdmann F, Raaschou-Nielsen O, Hvidtfeldt UA, Ketzel M, Brandt J, Khan J, et al. (2022). Residential road traffic and railway noise and risk of childhood cancer: A nationwide register-based case-control study in Denmark. Environ Res. 212(Pt A): 113180. https://doi.org/10.1016/j.envres.2022.113180 PMID: 35395236
  155. Erdmann F, Spix C, Schrappe M, Borkhardt A, Schuz J (2022). Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry. Lancet Reg Health Eur. 17: 100398. https://doi.org/10.1016/j.lanepe.2022.100398 PMID: 35573974
  156. Feletto E, Kovalevskiy EV, Schonfeld SJ, Moissonnier M, Olsson A, Kashanskiy SV, et al. (2022). Developing a company-specific job exposure matrix for the Asbest Chrysotile Cohort Study. Occup Environ Med. 79(5): 339-346. https://doi.org/10.1136/oemed-2021-107438 PMID: 34625507
  157. Foerster M, McCormack V, Anderson BO, Boucheron P, Zietsman A, Cubasch H, et al. (2022). Treatment guideline concordance, initiation, and abandonment in patients with non-metastatic breast cancer from the African Breast Cancer-Disparities in Outcomes (ABC-DO) cohort in sub-Saharan Africa: a prospective cohort study. Lancet Oncol. 23(6): 729-738. https://doi.org/10.1016/S1470-2045(22)00198-X PMID: 35550274
  158. Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, et al. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 28(12): 2563-2572. https://doi.org/10.1038/s41591-022-02109-2 PMID: 36404355
  159. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 51(3): 830-838. https://doi.org/10.1093/ije/dyac031 PMID: 35244716
  160. Hosseini B, Olsson A, Bouaoun L, Hall A, Hadji M, Rashidian H, et al. (2022). Lung cancer risk in relation to jobs held in a nationwide case-control study in Iran. Occup Environ Med. 79(12): 831-838. https://doi.org/10.1136/oemed-2022-108463 PMID: 36379677
  161. Karalexi MA, Katsimpris A, Panagopoulou P, Bouka P, Schuz J, Ntzani E, et al. (2022). Maternal lifestyle factors and risk of neuroblastoma in the offspring: A meta-analysis including Greek NARECHEM-ST primary data. Cancer Epidemiol. 77: 102055. https://doi.org/10.1016/j.canep.2021.102055 PMID: 35026707
  162. Karalexi MA, Markozannes G, Tagkas CF, Katsimpris A, Tseretopoulou X, Tsilidis KK, et al. (2022). Nutritional Status at Diagnosis as Predictor of Survival from Childhood Cancer: A Review of the Literature. Diagnostics (Basel). 12(10). https://doi.org/10.3390/diagnostics12102357 PMID: 36292046
  163. Kitajima T, Schuz J, Morita A, Ikeda W, Tanaka H, Togawa K, et al. (2022). Measurement of Intermediate Frequency Magnetic Fields Generated by Household Induction Cookers for Epidemiological Studies and Development of an Exposure Estimation Model. Int J Environ Res Public Health. 19(19). https://doi.org/10.3390/ijerph191911912 PMID: 36231220
  164. Masukume G, Mmbaga BT, Dzamalala CP, Mlombe YB, Finch P, Nyakunga-Maro G, et al. (2022). A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. Br J Cancer. 127(6): 1106-1115. https://doi.org/10.1038/s41416-022-01890-8 PMID: 35768549
  165. McCormack V, Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, et al. (2022). The evidence gap between alcohol consumption and oesophageal squamous cell carcinoma in east Africa – Authors’ reply. Lancet Glob Health. 10(5): e623. https://doi.org/10.1016/S2214-109X(22)00116-4 PMID: 35427516
  166. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, et al. (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. https://doi.org/10.1016/S2214-109X(21)00506-4 PMID: 34921758
  167. Murillo R, Ordonez-Reyes C, Caicedo-Martinez M, Vargas SP, Ariza E, Schuz J, et al. (2022). Coverage and Acceptability of Mobile Phone Messages for Cancer Prevention: a Population-Based Study in a Latin American Country. J Cancer Educ. 37(4): 1000-1008. https://doi.org/10.1007/s13187-020-01912-0 PMID: 33185816
  168. Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, et al. (2022). An international report on bacterial communities in esophageal squamous cell carcinoma. Int J Cancer. 151(11): 1947-1959. https://doi.org/10.1002/ijc.34212 PMID: 35837755
  169. Olsson A, Guha N, Bouaoun L, Kromhout H, Peters S, Siemiatycki J, et al. (2022). Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY). Cancer Epidemiol Biomarkers Prev. 31(7): 1433-1441. https://doi.org/10.1158/1055-9965.EPI-21-1428 PMID: 35437574
  170. Onyije FM, Olsson A, Baaken D, Erdmann F, Stanulla M, Wollschlager D, et al. (2022). Environmental Risk Factors for Childhood Acute Lymphoblastic Leukemia: An Umbrella Review. Cancers (Basel). 14(2). https://doi.org/10.3390/cancers14020382 PMID: 35053543
  171. Onyije FM, Olsson A, Erdmann F, Magnani C, Petridou E, Clavel J, et al. (2022). Parental occupational exposure to combustion products, metals, silica and asbestos and risk of childhood leukaemia: Findings from the Childhood Cancer and Leukaemia International Consortium (CLIC). Environ Int. 167: 107409. https://doi.org/10.1016/j.envint.2022.107409 PMID: 35908390
  172. Petrova D, Spacirova Z, Fernandez-Martinez NF, Ching-Lopez A, Garrido D, Rodriguez-Barranco M, et al. (2022). The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis. PLoS Med. 19(10): e1004110. https://doi.org/10.1371/journal.pmed.1004110 PMID: 36264841
  173. Pumpalova YS, Ayeni OA, Chen WC, Buccimazza I, Cacala S, Stopforth LW, et al. (2022). The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. Oncologist. 27(3): e233-e243. https://doi.org/10.1093/oncolo/oyab054 PMID: 35274708
  174. Schlehofer B, Blettner M, Moissonnier M, Deltour I, Giles GG, Armstrong B, et al. (2022). Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study. Eur J Epidemiol. 37(5): 503-512. https://doi.org/10.1007/s10654-022-00843-y PMID: 35118581
  175. Schuz J, Borkhardt A, Bouaoun L, Erdmann F (2022). The impact of the COVID-19 pandemic on the future incidence of acute lymphoblastic leukaemia in children: Projections for Germany under a COVID-19 related scenario. Int J Cancer. 151(1): 153-155. https://doi.org/10.1002/ijc.33992 PMID: 35253908
  176. Schuz J, Pirie K, Reeves GK, Floud S, Beral V (2022). Response to Moskowitz and Birnbaum, Taylor, Baldwin, et al. J Natl Cancer Inst. 114(11): 1555-1556. https://doi.org/10.1093/jnci/djac111 PMID: 35703934
  177. Schuz J, Pirie K, Reeves GK, Floud S, Beral V, Million Women Study C (2022). Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study. J Natl Cancer Inst. 114(5): 704-711. https://doi.org/10.1093/jnci/djac042 PMID: 35350069
  178. Simba H, Tromp G, Sewram V, Mathew CG, Chen WC, Kuivaniemi H (2022). Esophageal Cancer Genomics in Africa: Recommendations for Future Research. Front Genet. 13: 864575. https://doi.org/10.3389/fgene.2022.864575 PMID: 35401654
  179. Smith J, Togawa K, Dresler C, Hawari F, Zain ZM, Stewart B, et al. (2022). Smoking cessation after a cancer diagnosis: Commentary on special supplement in Cancer Epidemiology. Cancer Epidemiol. 79: 102210. https://doi.org/10.1016/j.canep.2022.102210 PMID: 35785684
  180. Straw C, Antelo VS, Paolino M, Murillo R, Espina C, Arrossi S (2022). Acceptability, relevance and feasibility of a Latin American and Caribbean Cancer Code: perceptions of decision makers and health professionals in Argentina. Ecancermedicalscience. 16: 23. PMID: WOS:000789034100001
  181. Straw C, Antelo VS, Paolino M, Murillo R, Espina C, Arrossi S (2022). Acceptability, appropriateness and feasibility of the Latin American and Caribbean Code against Cancer: perceptions of decision-makers and health professionals in Argentina. Ecancermedicalscience. 16: 1375. https://doi.org/10.3332/ecancer.2022.1375 PMID: 35702416
  182. Wade KH, Yarmolinsky J, Giovannucci E, Lewis SJ, Millwood IY, Munafo MR, et al. (2022). Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes Control. 33(5): 631-652. https://doi.org/10.1007/s10552-022-01562-1 PMID: 35274198
  183. Ward SV, Burton A, Tamimi RM, Pereira A, Garmendia ML, Pollan M, et al. (2022). The association of age at menarche and adult height with mammographic density in the International Consortium of Mammographic Density. Breast Cancer Res. 24(1): 49. https://doi.org/10.1186/s13058-022-01545-9 PMID: 35836268
  184. Yang SL, Togawa K, Gilmour S, Leon ME, Soerjomataram I, Katanoda K (2022). Projecting the impact of implementation of WHO MPOWER measures on smoking prevalence and mortality in Japan. Tob Control. https://doi.org/10.1136/tc-2022-057262 PMID: 36100264
  185. Zablotska LB, Zupunski L, Leuraud K, Lopes J, Hinkle J, Pugeda T, et al. (2022). Radiation and CNS effects: summary of evidence from a recent symposium of the Radiation Research Society. Int J Radiat Biol. 99(9): 1332-1342. https://doi.org/10.1080/09553002.2023.2142984 PMID: 36318723

 

 

 

 

Environment and Lifestyle Epidemiology
About Research Publications Related websites Personnel
Close Reading Mode
UP